Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-10-25

Clinical Trial Update: Non-drug Study to Evaluate the Suitability of Neurocognitive Tests and Functioning Scales for the Measurement of Cognitive and Functioning Changes in Children With Down Syndrome

View source ↗

Summary

This is a completed non-drug clinical trial evaluating neurocognitive tests and functioning scales for measuring cognitive and functional changes in children wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Down Syndrome | Status: COMPLETED